Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice.

Ling Li,Linjiang Song,Xiaowei Liu,Xi Yang,Xia Li,Tao He,Ning Wang,Suleixin Yang,Chuan Yu,Tao Yin,Yanzhu Wen,Zhiyao He,Xiawei Wei,Weijun Su,Qinjie Wu,Shaohua Yao,Changyang Gong,Yuquan Wei
DOI: https://doi.org/10.1021/acsnano.6b04261
IF: 17.1
2016-01-01
ACS Nano
Abstract:CRISPR-Cas9 has emerged as a versatile genome-editing platform. However, due to the large size of the commonly used CRISPR-Cas9 system, its effective delivery has been a challenge and limits its utility for basic research and therapeutic applications. Herein, a multifunctional nucleus-targeting "core-shell" artificial virus (RRPHC) was constructed for the delivery of CRISPR-Cas9 system. The artificial virus could efficiently load with the CRISPR-Cas9 system, accelerate the endosomal escape, and promote the penetration into the nucleus without additional nuclear-localization signal, thus enabling targeted gene disruption. Notably, the artificial virus is more efficient than SuperFect, Lipofectamine 2000, and Lipofectamine 3000. When loaded with a CRISPR-Cas9 plasmid, it induced higher targeted gene disruption efficacy than that of Lipofectamine 3000. Furthermore, the artificial virus effectively targets the ovarian cancer via dual-receptor-mediated endocytosis and had minimum side effects. When loaded with the Cas9-hMTH1 system targeting MTH1 gene, RRPHC showed effective disruption of MTH1 in vivo. This strategy could be adapted for delivering CRISPR-Cas9 plasmid or other functional nucleic acids in vivo.
What problem does this paper attempt to address?